Evidence map›Paper›PMID 40709965›Full record

ArticleEuropean journal of investigation in health, psychology and education2025

Temporal Associations Between Cognitive Impairment and Depression in Older Adults: A Longitudinal Analysis.

Jesús Herrera-Imbroda, Vera Carbonell-Aranda, Gloria Guerrero-Pertiñez, Pilar Basnestein-Fonseca, Peter Anderberg, Esperanza Varela-Moreno, Antonio Cuesta-Vargas, Maite Garolera, Evi Lemmens, Johan Sanmartin Berglund and 3 more

Abstract read
In one paragraph

Article in European journal of investigation in health, psychology and education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jesús Herrera-ImbrodaMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.ORCID 0000-0002-9170-9909
Vera Carbonell-ArandaMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.ORCID 0000-0002-2397-4276
Gloria Guerrero-PertiñezMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.ORCID 0000-0002-4097-6628
Pilar Basnestein-FonsecaCudeca Foundation, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), 29631 Málaga, Spain.ORCID 0000-0003-2767-8017
Peter AnderbergDepartment of Health, Blekinge Institute of Technology, 37179 Karlskrona, Sweden.ORCID 0000-0001-9870-8477
Esperanza Varela-MorenoMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.
Antonio Cuesta-VargasDepartment of Physiotherapy, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University of Malaga, 29071 Málaga, Spain.ORCID 0000-0002-8880-4315
Maite GaroleraBrain, Cognition and Behavoir-Clinical Research, Consorci Sanitari de Terrasa, 08227 Barcelona, Spain.ORCID 0000-0001-7443-8249
Evi LemmensFaculty of Health, Centre of Expertise Health Innovation, University Colleges Leuven-Limburg (UCLL), 3600 Genk, Belgium.
Johan Sanmartin BerglundDepartment of Health, Blekinge Institute of Technology, 37179 Karlskrona, Sweden.ORCID 0000-0003-4312-2246
Fermin Mayoral-CleriesMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.ORCID 0000-0002-9710-9672
Jessica Marian Goodman-CasanovaMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.
Jose Guzman-ParraMental Health Department, The Biomedical Research Institute of Málaga and Nanomedicine Plattform (IBIMA Bionand Platform), University Regional Hospital of Málaga, 29009 Málaga, Spain.

Funding

European Commission 643399
6 · The paper itself

Abstract

Depression and cognitive impairment frequently co-occur in older adults, but their temporal relationship remains unclear. While depression is often considered a risk factor for cognitive decline, evidence is mixed, particularly in individuals with mild cognitive impairment or early dementia (MCI/ED). This study analyzed longitudinal data from 1086 participants (M = 74.49, SD = 7.24) in the SMART4MD clinical trial, conducted in Spain and Sweden over 18 months, with assessments every six months. Cognitive impairment was measured using the Mini-Mental State Examination, and depression was assessed with the Geriatric Depression Scale-15. Findings revealed a concurrent association between depressive symptoms and cognitive impairment. In regression mixed analysis, depression levels predicted increased cognitive decline over time, but no evidence was found for cognitive impairment predicting future depression. These associations were confirmed using a bivariate latent growth curve model with cross-lagged paths, which revealed early but attenuating bidirectional effects between depression and cognition. These results highlight depression as a medium-term risk factor for cognitive decline, emphasizing the importance of addressing depressive symptoms to mitigate cognitive deterioration in MCI/ED populations.

Indexed as

agingdementiadepressionmild cognitive impairment

Identifiers

PMID40709965
PMCPMC12293492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.